Macrophage migration inhibitory factor (MIF) expression in human malignant gliomas contributes to immune escape and tumour progression (original) (raw)
Al Abed Y, Dabideen D, Aljabari B et al (2005) ISO-1 binding to the tautomerase active site of MIF inhibits its pro-inflammatory activity and increases survival in severe sepsis. J Biol Chem 280:36541–36544 ArticlePubMedCAS Google Scholar
Al-Abed Y, Metz CN, Cheng KF et al (2011) Thyroxine is a potential endogenous antagonist of macrophage migration inhibitory factor (MIF) activity. Proc Natl Acad Sci USA 108(20):8224–8227 ArticlePubMedCAS Google Scholar
Amin MA, Volpert OV, Woods JM, Kumar P, Harlow LA, Koch AE (2003) Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase. Circ Res 93(4):321–329 ArticlePubMedCAS Google Scholar
Apte RS, Sinha D, Mayhew E, Wistow GJ, Niederkorn JY (1998) Cutting edge: role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege. J Immunol 160(12):5693–5696 PubMedCAS Google Scholar
Bach JP, Deuster O, Balzer-Geldsetzer M, Meyer B, Dodel R, Bacher M (2009) The role of macrophage inhibitory factor in tumourigenesis and central nervous system tumours. Cancer 115:2031–2040 ArticlePubMedCAS Google Scholar
Bacher M, Deuster O, Aljabari B et al (2010) The role of macrophage migration inhibitory factor in Alzheimer’s disease. Mol Med 16(3–4):116–121 PubMedCAS Google Scholar
Bacher M, Meinhardt A, Lan HY et al (1998) MIF expression in the rat brain: implications for neuronal function. Mol Med 4(4):217–230 PubMedCAS Google Scholar
Bacher M, Schrader J, Thompson N et al (2003) Up-regulation of macrophage migration inhibitory factor gene and protein expression in glial tumour cells during hypoxic and hypoglycemic stress indicates a critical role for angiogenesis in glioblastoma multiforme. Am J Pathol 162(1):11–17 ArticlePubMedCAS Google Scholar
Baron N, Deuster O, Noelker C et al (2011) Role of macrophage migration inhibitory factor in primary glioblastoma multiforme cells. J Neurosci Res 89:711–717 ArticlePubMedCAS Google Scholar
Bauer S, Groh V, Wu J et al (1999) Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285:727–729 ArticlePubMedCAS Google Scholar
Baumann R, Casaulta C, Simon D, Conus S, Yousefi S, Simon HU (2003) Macrophage migration inhibitory factor delays apoptosis in neutrophils by inhibiting the mitochondria-dependent death pathway. FASEB J 17(15):2221–2230 ArticlePubMedCAS Google Scholar
Bernhagen J, Krohn R, Lue H et al (2007) MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 13:587–596 ArticlePubMedCAS Google Scholar
Bloom BR, Bennett B (1966) Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153:80–82 ArticlePubMedCAS Google Scholar
Bucala R, Donnelly SC (2007) Macrophage migration inhibitory factor: a probable link between inflammation and cancer. Immunity 26:281–285 ArticlePubMedCAS Google Scholar
Calandra T, Roger T (2003) Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 3:791–800 ArticlePubMedCAS Google Scholar
Cludts S, Decaestecker C, Johnson B et al (2010) Increased expression of macrophage migration inhibitory factor during progression to hypopharyngeal squamous cell carcinoma. Anticancer Res 30(9):3313–3319 PubMed Google Scholar
Craig-Schapiro R, Kuhn M, Xiong C et al (2011) Multiplexed immunoassay panel identifies novel CSF biomarkers for Alzheimer’s disease diagnosis and prognosis. PLoS One 6(4):e18850 ArticlePubMedCAS Google Scholar
Daun JM, Cannon JG (2000) Macrophage migration inhibitory factor antagonizes hydrocortisone-induced increases in cytosolic IκBα. Am J Physiol Regul Integr Comp Physiol 279:R1043–R1049 PubMedCAS Google Scholar
Dumitru CA, Gholaman H, Trellakis S et al (2011) Tumour-derived macrophage migration inhibitory factor modulates the biology of head and neck cancer cells via neutrophil activation. Int J Cancer. doi:10.1002/ijc.25991
Eisele G, Wischhusen J, Mittelbronn M et al (2006) TGF-β and metalloproteinases differentially suppress NKG2D ligand surface expression on malignant glioma cells. Brain 129:2416–2425 ArticlePubMed Google Scholar
Engelhorn T, Savaskan NE, Schwarz MA et al (2009) Cellular characterization of the peritumoural edema zone in malignant brain tumours. Cancer Sci 100(10):1856–1862 ArticlePubMedCAS Google Scholar
Fingerle-Rowson G, Petrenko O, Metz CN et al (2003) The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting. Proc Natl Acad Sci USA 100(16):9354–9359 ArticlePubMedCAS Google Scholar
Friese MA, Wischhusen J, Wick W et al (2004) RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumourigenicity in vivo. Cancer Res 64:7596–7603 ArticlePubMedCAS Google Scholar
Groh V, Rhinehart R, Secrist H, Bauer S, Grabstein KH, Spies T (1999) Broad tumour-associated expression and recognition by tumour-derived γδT cells of MICA and MICB. Proc Natl Acad Sci USA 96:6879–6884 ArticlePubMedCAS Google Scholar
Hudson JD, Shoaibi MA, Maestro R, Carnero A, Hannon GJ, Beach DH (1999) A proinflammatory cytokine inhibits p53 tumour suppressor activity. J Exp Med 190(10):1375–1382 ArticlePubMedCAS Google Scholar
Jung H, Seong HA, Ha H (2008) Direct interaction between NM23–H1 and macrophage migration inhibitory factor (MIF) is critical for alleviation of MIF-mediated suppression of p53 activity. J Biol Chem 283(47):32669–32679 ArticlePubMedCAS Google Scholar
Koda M, Nishio Y, Hashimoto M et al (2004) Up-regulation of macrophage migration-inhibitory factor expression after compression-induced spinal cord injury in rats. Acta Neuropathol 108:31–36 ArticlePubMedCAS Google Scholar
Krockenberger M, Dombrowski Y, Weidler C et al (2008) Macrophage migration inhibitory factor contributes to the immune escape of ovarian cancer by down-regulating NKG2D. J Immunol 180(11):7338–7348 PubMedCAS Google Scholar
Legendre H, Decaestecker C, Nagy N et al (2003) Prognostic values of galectin-3 and the macrophage migration inhibitory factor (MIF) in human colorectal cancers. Mod Pathol 16(5):491–504 ArticlePubMed Google Scholar
Leng L, Metz CN, Fang Y et al (2003) MIF signal transduction initiated by binding to CD74. J Exp Med 197:1467–1476 ArticlePubMedCAS Google Scholar
Liao H, Bucala R, Mitchell RA (2003) Adhesion-dependent signaling by macrophage migration inhibitory factor (MIF). J Biol Chem 278:76–81 ArticlePubMedCAS Google Scholar
Matsunaga J, Sinha D, Pannell L et al (1999) Enzyme activity of macrophage migration inhibitory factor toward oxidized catecholamines. J Biol Chem 274(6):3268–3271 ArticlePubMedCAS Google Scholar
Matsunaga J, Sinha D, Solano F, Santis C, Wistow G, Hearing V (1999) Macrophage migration inhibitory factor (MIF)—its role in catecholamine metabolism. Cell Mol Biol 45(7):1035–1040 PubMedCAS Google Scholar
Mitchell RA (2004) Mechanisms and effectors of MIF-dependent promotion of tumourigenesis. Cell Signal 16:13–19 ArticlePubMedCAS Google Scholar
Mitchell RA, Bucala R (2000) Tumour growth-promoting properties of macrophage migration inhibitory factor (MIF). Semin Cancer Biol 10:359–366 ArticlePubMedCAS Google Scholar
Morand EF, Leech M, Bernhagen J (2006) MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis. Nat Rev Drug Discov 5:399–410 ArticlePubMedCAS Google Scholar
Munaut C, Boniver J, Foidart JM, Deprez M (2002) Macrophage migration inhibitory factor (MIF) expression in human glioblastomas correlates with vascular endothelial growth factor (VEGF) expression. Neuropathol Appl Neurobiol 28(6):452–460 ArticlePubMedCAS Google Scholar
Nishibori M, Nakaya N, Mori S, Saeki K (1997) Immunohistochemical localization of macrophage migration inhibitory factor (MIF) in tanycytes, subcommissural organ and choroid plexus in the rat brain. Brain Res 758:259–262 ArticlePubMedCAS Google Scholar
Oda S, Oda T, Nishi K et al (2008) Macrophage migration inhibitory factor activates hypoxia-inducible factor in a p53-dependent manner. PLoS One 3(5):e2215 ArticlePubMed Google Scholar
Ogawa H, Nishihira J, Sato Y et al (2000) An antibody for macrophage migration inhibitory factor suppresses tumour growth and inhibits tumour-associated angiogenesis. Cytokine 12(4):309–314 ArticlePubMedCAS Google Scholar
Ohgaki H, Kleihues P (2005) Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 64(6):479–489 PubMedCAS Google Scholar
Ohkawara T, Nishihira J, Takeda H, Asaka M, Sugiyama T (2005) Pathophysiological roles of macrophage migration inhibitory factor in gastrointestinal, hepatic, and pancreatic disorders. J Gastroenterol 40(2):117–122 ArticlePubMedCAS Google Scholar
Østergaard C, Benfield T (2009) Macrophage migration inhibitory factor in cerebrospinal fluid from patients with central nervous system infection. Crit Care 13(3):R101 ArticlePubMed Google Scholar
Petrenko O, Fingerle-Rowson G, Peng T, Mitchell RA, Metz CN (2003) Macrophage migration inhibitory factor deficiency is associated with altered cell growth and reduced susceptibility to Ras-mediated transformation. J Biol Chem 278:11078–11085 ArticlePubMedCAS Google Scholar
Piette C, Deprez M, Roger T, Noël A, Foidart JM, Munaut C (2009) The dexamethasone-induced inhibition of proliferation, migration, and invasion in glioma cell lines is antagonized by macrophage migration inhibitory factor (MIF) and can be enhanced by specific MIF inhibitors. J Biol Chem 284(47):32483–32492 ArticlePubMedCAS Google Scholar
Popp J, Bacher M, Kölsch H et al (2009) Macrophage migration inhibitory factor in mild cognitive impairment and Alzheimer’s disease. J Psychiatr Res 43(8):749–753 ArticlePubMed Google Scholar
Rendon BE, Roger T, Teneng I et al (2007) Regulation of human lung adenocarcinoma cell migration and invasion by macrophage migration inhibitory factor. J Biol Chem 282(41):29910–29918 ArticlePubMedCAS Google Scholar
Repp AC, Mayhew ES, Apte S, Niederkorn JY (2000) Human uveal melanoma cells produce macrophage migration-inhibitory factor to prevent lysis by NK cells. J Immunol 165:710–715 PubMedCAS Google Scholar
Sasaki Y, Kasuya K, Nishihira J et al (2002) Suppression of tumour growth through introduction of an antisense plasmid of macrophage migration inhibitory factor. Int J Mol Med 10(5):579–583 PubMedCAS Google Scholar
Schrader J, Deuster O, Rinn B et al (2009) Restoration of contact inhibition in human glioblastoma cell lines after MIF knockdown. BMC Cancer 9:464 ArticlePubMed Google Scholar
Seike T, Fujita K, Yamakawa Y et al (2011) Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis. Clin Exp Metastasis 28:13–25 ArticlePubMedCAS Google Scholar
Shi X, Leng L, Wang T et al (2006) CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 25:595–606 ArticlePubMedCAS Google Scholar
Tarnowski M, Grymula K, Liu R et al (2010) Macrophage migration inhibitory factor is secreted by rhabdomyosarcoma cells, modulates tumour metastasis by binding to CXCR4 and CXCR7 receptors and inhibits recruitment of cancer-associated fibroblasts. Mol Cancer Res 8(10):1328–1343 ArticlePubMedCAS Google Scholar
Vedder H, Krieg JC, Gerlach B, Gemsa D, Bacher M (2000) Expression and glucocorticoid regulation of macrophage migration inhibitory factor (MIF) in hippocampal and neocortical rat brain cells in culture. Brain Res 869(1–2):25–30 ArticlePubMedCAS Google Scholar
White ES, Flaherty KR, Carskadon S et al (2003) Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis. Clin Cancer Res 9(2):853–860 PubMedCAS Google Scholar
Wischhusen J, Naumann U, Ohgaki H, Rastinejad F, Weller M (2003) CP-31398, a novel p53-stabilizing agent, induces p53-dependent and p53-independent glioma cell death. Oncogene 22:8233–8245 ArticlePubMedCAS Google Scholar
Xia HH, Yang Y, Chu KM et al (2009) Serum macrophage migration-inhibitory factor as a diagnostic and prognostic biomarker for gastric cancer. Cancer 115(23):5441–5449 ArticlePubMedCAS Google Scholar